January 31, 2017
Mochida Pharmaceutical filed an application in Japan seeking approval for a biosimilar version of rheumatoid arthritis (RA) treatment Enbrel (etanercept) in the October-December period last year, the company revealed at an earnings conference on January 30. The drug maker did...read more